Group structure
17 companies in 5 countries
Loadingโฆ
17 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 125
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AKTEN3.5% ยท GEL | Lidocaine | United States | Marketed | 2008 |
| Allerg-Abak 20 mg/ml, oogdruppels, oplossingOogdruppels, oplossing | Dinatriumcromoglicaat | Netherlands | Authorised | 2004 |
| Altriabak 0,25 mg/ml, oogdruppels, oplossingOogdruppels, oplossing | Ketotifen | Netherlands | Authorised | 2010 |
| Aprokam 50 mg poeder voor oplossing voor injectiePoeder voor oplossing voor injectie | Cefuroxime | Netherlands | Authorised | 2012 |
| AZASITE1% ยท Solution/drops | Azithromycin | United States | Marketed | 2007 |
| AZYDROP 15mg/g, COLIRIO EN SOLUCION EN ENVASE UNIDOSIS3,75 mg ยท Colirio en soluciรณn en envase unidosis | Azithromycin | Spain | Marketed | 2008 |
| Azyter 15 mg/g kapi za oko, otopina u jednodoznom spremnikukapi za oko, otopina u jednodoznom spremniku | Azithromycin | Croatia | Marketed | 2018 |
| Azyter 15 mg/g, oogdruppels, oplossingOogdruppels, oplossing | Azithromycin | Netherlands | Authorised | 2008 |
| Bazyt 15 mg/g, oogdruppels, oplossingOogdruppels, oplossing | Azithromycin | Netherlands | Authorised | 2013 |
| BENTIFEN 0,25mg/ml COLIRIO EN SOLUCION0,345 mg ยท Colirio en soluciรณn | Ketotifen | Spain | Marketed | 2001 |
| BETIMOL0.25% | 0.5% ยท Solution/drops | Timolol | United States | Marketed | 1995 |
| Carteabak 1%, oogdruppels,oplossingOogdruppels, oplossing | Carteolol | Netherlands | Authorised | 2004 |
| Carteabak 2%, oogdruppels,oplossingOogdruppels, oplossing | Carteolol | Netherlands | Authorised | 2004 |
| COSOPT2% base; 0.5% base ยท Solution/drops | Dorzolamide, Timolol | United States | Marketed | 1998 |
| COSOPT PF2% base; 0.5% base ยท Solution/drops | Dorzolamide, Timolol | United States | Marketed | 2012 |
| CYKLX8% base ยท Solution/drops | Articaine | United States | Not marketed | 2025 |
| DEXAFREE 1 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS1,093 mg/ml ยท Colirio en soluciรณn en envase unidosis | Dexamethasone | Spain | Marketed | 2025 |
| DEXAFREE 1 MG/ML COLIRIO EN SOLUCIรN EN ENVASE UNIDOSIS1 mg/ml ยท Colirio en soluciรณn en envase unidosis | Dexamethasone | Spain | Marketed | 2024 |
| DEXAFREE 1 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS1,093 mg ยท Colirio en soluciรณn en envase unidosis | Dexamethasone | Spain | Marketed | 2018 |
| DEXAFREE 1 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS0,1093 g ยท Colirio en soluciรณn en envase unidosis | Dexamethasone | Spain | Marketed | 2006 |
| DEXAFREE 1 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS0,1093 g ยท Colirio en soluciรณn en envase unidosis | Dexamethasone | Spain | Authorised | 2024 |
| Dexafree 1mg/ml colirio en solucion0,1093 g ยท Colirio en soluciรณn | Dexamethasone | Spain | Marketed | 2013 |
| DEXAFREE 1mg/ml colirio en solucion en envase unidosis1 mg ยท Colirio en soluciรณn en envase unidosis | Dexamethasone | Spain | Marketed | 2014 |
| DICLOABAK 1 mg/ml COLIRIO EN SOLUCION10 mg ยท Colirio en soluciรณn | Diclofenac | Spain | Marketed | 2007 |
| Dicloabak 1 mg/ml, oogdruppels, oplossingOogdruppels, oplossing | Diclofenac | Netherlands | Authorised | 2007 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 49 | 42 | 7 | CompaniesAll medicines |
| Netherlands | 37 | 37 | 0 | CompaniesAll medicines |
| Romania | 14 | 0 | 14 | CompaniesAll medicines |
| United States | 9 | 9 | 0 | CompaniesAll medicines |
| Croatia | 8 | 8 | 0 | CompaniesAll medicines |
| Canada | 5 | 5 | 0 | CompaniesAll medicines |
| Saudi Arabia | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, France, Germany, Italy, Serbia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Federal Commercial Registry Office;exact dataset/law title,source URI/link and retrieval date;Prognia separately labelled normalization;no endorsement.
Licence: opendata.swiss terms_by
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Bundesinstitut fรผr Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Licence: commercial redistribution permission not established
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche dโentreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods JanuaryโSeptember 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep THEAโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.